Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1

Review

Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results

       
Total article views   HTML views PDF downloads Totals
6,757 Dovepress* 6,757+ 1,676 8,433
Totals 6,757 1,676 8,433
*Since 8 February 2008
+Since July 2016

View citations on Google Scholar